HealthPhoto: MintSupreme Court Criticizes Centre, Hospitals Over Medicine Price Mark-ups
The Supreme Court criticized the Centre for failing to justify steep markups on medicines, questioning delays in capping trade margins on anti-cancer drugs and whether patient welfare was prioritized over commercial interests. The court also questioned hospitals on selling medicines at MRPs far above procurement costs. The hearing followed a government cap on trade margins at 30% for selected anti-cancer medicines from October 17.
Mint·




